Skip to main content
CG Invites Co., Ltd. logo

CG Invites Co., Ltd. — Investor Relations & Filings

Ticker · 083790 ISIN · KR7083790006 KO Manufacturing
Filings indexed 450 across all filing types
Latest filing 2024-03-15 Annual Report
Country KR South Korea
Listing KO 083790

About CG Invites Co., Ltd.

https://cginvites.com/en

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 24th fiscal year (2023), covering the period from January 1, 2023, to December 31, 2023. In the South Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K Annual Report, containing comprehensive company information, financial data, and management disclosures. It is not an announcement or a summary, but the full annual filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange. FY 2023
2024-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for CG Invites Co., Ltd. It contains the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and information regarding electronic voting and proxy solicitation. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and request their participation/votes. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category.
2024-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used to solicit shareholder votes for an upcoming General Meeting. It contains details on the meeting agenda, proxy solicitation procedures, and financial statements. This corresponds to the 'Proxy Solicitation & Information Statement' category.
2024-03-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. This document details changes in share ownership by a major shareholder (Joong Myung Cho) in the company 'CG Invites'. Since this is a mandatory disclosure of significant shareholding changes (crossing thresholds or reporting changes in ownership), it falls under the 'Major Shareholding Notification' category.
2024-03-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) from a Korean company (CG Invites). This type of filing is a standard regulatory requirement for insiders and major shareholders to disclose changes in their shareholdings. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of share transactions by company directors, executives, and major shareholders.
2024-03-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. It details the acquisition of shares, changes in shareholding percentages, and the purpose of holding (influencing management). This falls under the category of Major Shareholding Notification (MRQ).
2024-03-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.